Skip to main content
QURE
NASDAQ Life Sciences

UniQure Stock Plunges 48% as Huntington's Drug Data Misses Statistical Significance

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$22
Mkt Cap
$2.713B
52W Low
$8.73
52W High
$71.5
52W Position info
152% above low
Off High info
69% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

QURE has more than doubled off its 52-week low of $8.73.

Summary

UniQure shares crashed 48% to $20.50 premarket after 48-month Phase I/II data for AMT-130 in Huntington's disease showed only 44% slowing of disease progression and missed statistical significance. The company insists the data still support approval, pointing to statistically strong 36-month results for all 15 high-dose patients, which form the basis of its BLA. This follows the BLA submission announced earlier this month and the FDA's prior skepticism about Phase I/II data sufficiency. The market is clearly questioning whether the FDA will accept the application given the mixed long-term results. Watch for any FDA response to the BLA and further analysis of the dropout-adjusted data.

At the time of this announcement, QURE was trading at $22.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.7B. The 52-week trading range was $8.73 to $71.50. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

QURE - Latest Insights

QURE
Nov 04, 2026, 7:28 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $22.60
Real-time Price: $22.03 info
Change: -$0.5735 (-3%) info
Market Cap: $1.543B info
QURE
Nov 04, 2026, 7:10 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.44
Real-time Price: $22.03 info
Change: -$0.415 (-2%) info
Market Cap: $1.543B info
QURE
Nov 02, 2026, 7:05 AM EST
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $27.66
Real-time Price: $22.03 info
Change: -$5.63 (-20%) info
Market Cap: $1.543B info
QURE
Sep 29, 2026, 9:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $22.20
Real-time Price: $22.03 info
Change: -$0.175 (-0.79%) info
Market Cap: $1.543B info
QURE
Sep 29, 2026, 7:12 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $11.75
Real-time Price: $22.03 info
Change: +$10.27 (+87%) info
Market Cap: $1.543B info